Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

Richard P. Gale*, Ian Pearce, Nicole Eter, Faruque Ghanchi, Frank G. Holz, Steffen Schmitz-Valckenberg, Konstantinos Balaskas, Ben J.L. Burton, Susan M. Downes, Haralabos Eleftheriadis, Sheena George, David Gilmour, Robin Hamilton, Andrew J. Lotery, Nishal Patel, Priya Prakash, Cynthia Santiago, Saju Thomas, Deepali Varma, Gavin WaltersMichael Williams, Armin Wolf, Rosina H. Zakri, Franklin Igwe, Filis Ayan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
23 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study'. Together they form a unique fingerprint.

Medicine & Life Sciences